The NTD Supply Chain Forum-Strengthening the backbone of NTD programs

Ashley A. Souza; Cassandra Holloway; Tijana Williams

doi:10.1371/journal.pntd.0008818

The NTD Supply Chain Forum-Strengthening the backbone of NTD programs

Ashley A. Souza, Cassandra Holloway, Tijana Williams

Research output: Contribution to journal › Article › peer-review

12 Citations (Scopus)

Abstract

Global programs targeting 5 preventive chemotherapy neglected tropical diseases (PC-NTDs) have scaled up rapidly in recent decades due, in large part, to the generous drug donations from 6 pharmaceutical companies-Eisai; Johnson & Johnson (J&J); GlaxoSmithKline (GSK); Merck & Co., Inc., Kenilworth, New Jersey, United States of America (MSD); Merck KgaA; and Pfizer. Today, the scale of the PC-NTD drug donation programs is staggering. Nearly 15 billion tablets have been manufactured, packaged, shipped, and distributed in order to reach the people in need. The supply chains established to support such massive operations are enormously complex. Here, we describe a unique public-private partnership that was formed to bring together supply chain expertise to overcome the critical challenges associated with such large-scale production and delivery of donated pharmaceutical products.

Original language	English
Pages (from-to)	e0008818
Journal	PLoS Neglected Tropical Diseases
Volume	14
Issue number	11
DOIs	https://doi.org/10.1371/journal.pntd.0008818
Publication status	Published - 1 Nov 2020
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1371/journal.pntd.0008818Licence: CC BY

Cite this

@article{692963511b5f4e1098d7044f1bfc047d,

title = "The NTD Supply Chain Forum-Strengthening the backbone of NTD programs",

abstract = "Global programs targeting 5 preventive chemotherapy neglected tropical diseases (PC-NTDs) have scaled up rapidly in recent decades due, in large part, to the generous drug donations from 6 pharmaceutical companies-Eisai; Johnson \& Johnson (J\&J); GlaxoSmithKline (GSK); Merck \& Co., Inc., Kenilworth, New Jersey, United States of America (MSD); Merck KgaA; and Pfizer. Today, the scale of the PC-NTD drug donation programs is staggering. Nearly 15 billion tablets have been manufactured, packaged, shipped, and distributed in order to reach the people in need. The supply chains established to support such massive operations are enormously complex. Here, we describe a unique public-private partnership that was formed to bring together supply chain expertise to overcome the critical challenges associated with such large-scale production and delivery of donated pharmaceutical products.",

author = "Souza, \{Ashley A.\} and Cassandra Holloway and Tijana Williams",

year = "2020",

month = nov,

day = "1",

doi = "10.1371/journal.pntd.0008818",

language = "English",

volume = "14",

pages = "e0008818",

journal = "PLoS Neglected Tropical Diseases",

issn = "1935-2727",

publisher = "Public Library of Science",

number = "11",

}

TY - JOUR

T1 - The NTD Supply Chain Forum-Strengthening the backbone of NTD programs

AU - Souza, Ashley A.

AU - Holloway, Cassandra

AU - Williams, Tijana

PY - 2020/11/1

Y1 - 2020/11/1

N2 - Global programs targeting 5 preventive chemotherapy neglected tropical diseases (PC-NTDs) have scaled up rapidly in recent decades due, in large part, to the generous drug donations from 6 pharmaceutical companies-Eisai; Johnson & Johnson (J&J); GlaxoSmithKline (GSK); Merck & Co., Inc., Kenilworth, New Jersey, United States of America (MSD); Merck KgaA; and Pfizer. Today, the scale of the PC-NTD drug donation programs is staggering. Nearly 15 billion tablets have been manufactured, packaged, shipped, and distributed in order to reach the people in need. The supply chains established to support such massive operations are enormously complex. Here, we describe a unique public-private partnership that was formed to bring together supply chain expertise to overcome the critical challenges associated with such large-scale production and delivery of donated pharmaceutical products.

AB - Global programs targeting 5 preventive chemotherapy neglected tropical diseases (PC-NTDs) have scaled up rapidly in recent decades due, in large part, to the generous drug donations from 6 pharmaceutical companies-Eisai; Johnson & Johnson (J&J); GlaxoSmithKline (GSK); Merck & Co., Inc., Kenilworth, New Jersey, United States of America (MSD); Merck KgaA; and Pfizer. Today, the scale of the PC-NTD drug donation programs is staggering. Nearly 15 billion tablets have been manufactured, packaged, shipped, and distributed in order to reach the people in need. The supply chains established to support such massive operations are enormously complex. Here, we describe a unique public-private partnership that was formed to bring together supply chain expertise to overcome the critical challenges associated with such large-scale production and delivery of donated pharmaceutical products.

U2 - 10.1371/journal.pntd.0008818

DO - 10.1371/journal.pntd.0008818

M3 - Article

SN - 1935-2727

VL - 14

SP - e0008818

JO - PLoS Neglected Tropical Diseases

JF - PLoS Neglected Tropical Diseases

IS - 11

ER -

The NTD Supply Chain Forum-Strengthening the backbone of NTD programs

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this